The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10317 malaria professionals are enjoying the free benefits of MalariaWorld today

nonimmune subject

Clinical Therapeutics: Randomized, Double-Blind Study of the Safety, Tolerability, and Efficacy of Tafenoquine versus Mefloquine for Malaria Prophylaxis in Nonimmune Subjects{triangledown}

January 28, 2010 - 12:14 -- Kabogo Ndegwa
Author(s): 
Peter E. Nasveld, Michael D. Edstein, Mark Reid, Leonard Brennan, Ivor E. Harris, Scott J. Kitchener, Peter A. Leggat, Philip Pickford, Caron Kerr, Colin Ohrt, William Prescott, and the Tafenoquine Study Team
Reference: 
Antimicrobial Agents and Chemotherapy, February 2010, p. 792-798, Vol. 54, No. 2

This study represents the first phase III trial of the safety, tolerability, and effectiveness of tafenoquine for malaria prophylaxis.

Subscribe to RSS - nonimmune subject